Medications

UK authorizes Merck antiviral pill, 1st shown to treat COVID

Britain granted conditional authorization on Thursday to the first pill shown to successfully treat COVID-19 so far. It also is the first country to OK the treatment from drugmaker Merck, although it wasn't immediately clear ...

Diseases, Conditions, Syndromes

EU medicines agency starts review of Merck oral COVID drug

The EU's medicines watchdog said on Monday it had started reviewing an oral COVID medication from the US pharmaceutical firm Merck, raising hopes for an easy-to-administer treatment to reduce serious or deadly cases.

Medications

Merck recalls cholesterol drug Liptruzet (Update)

(HealthDay)—Packaging defects have prompted a recall of a combination cholesterol drug called Liptruzet, produced by Merck & Co., temporarily affecting the entire U.S. stock.

Immunology

Sublingual immunotherapy tablet safe in asthma patients

(HealthDay)—For individuals with asthma and allergic rhinitis with/without conjunctivitis (AR/C), treatment with a Timothy grass sublingual immunotherapy tablet (SLIT-tablet) seems safe, according to research published ...

Medications

Merck: FDA won't OK its combo cholesterol drug now

(AP) -- Federal regulators have rejected Merck & Co.'s new combination cholesterol drug, which includes a generic version of the mega-blockbuster Lipitor - at least for now.

Medications

Merck seeks new OK for cancer drug, reorganization on track

Drugmaker Merck & Co. is ratcheting up its race with rival Bristol-Myers Squibb Co. for leadership in one of today's hottest research areas, immuno-oncology, which harnesses the immune system to fight cancer.

Medications

FDA OKs Cubist antibiotic for serious infections

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Medications

Bristol-Myers ends hepatitis C drug development

(AP)—Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.

Medications

Merck pays $830 M to settle class-action case over Vioxx

The drugmaker Merck is paying $830 million to resolve a federal class-action lawsuit involving shareholders and the painkiller Vioxx, which was pulled from the market years ago over safety concerns.

page 5 from 14